U.S., Aug. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07131631) titled 'Secondary Mitral Regurgitation Treatment With MitraClip and Assessment by Cardiac Magnetic Resonance' on Aug. 06.
Brief Summary: This is a multi-center, prospective, observational study designed to evaluate the impact of LV myocardial fibrosis extent assessed by CMR on LV reverse remodeling and clinical outcomes post TEER. The target sample will be up to 125 patients enrolled to achieve 100 evaluable at 6 months of follow-up. Enrollment will occur at up to eight centers.
Study Start Date: March 03, 2022
Study Type: OBSERVATIONAL
Condition:
Heart Failure and Reduced Ejection Fraction
Functional Mitral Regurgitation
Intervention:...